Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- FDA Grants Breakthrough Therapy Designation to Pfizer’s Trumenba for Prevention of Invasive Meningococcal B Disease
- FDA Grants Fast Track Status to MeiraGTx’s AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa Due to RPGR Deficiency
- Prime Therapeutics Finds Poor Adherence to High-Cost Multiple Sclerosis Therapy
- FDA Requests Additional Information for Pfizer’s Application for its Proposed Trastuzumab Biosimilar
- Ocrevus Significantly Reduces Disease Activity and Disability Progression in Relapsing Multiple Sclerosis
- Biogen Pays $1 Billion to Expand Partnership with Ionis to Develop Drugs for Various Neurological Diseases
- Argos Discontinues Late-Stage Trial of Investigational Vaccine for Patients with Metastatic Renal Cell Carcinoma
- Theravance Biopharma’s Trelegy Ellipta Significantly Benefits COPD Patients in Landmark IMPACT Study
- GW Pharma Wins Unanimous Recommendation from FDA Committee for Approval of its Cannabis-Based Drug
- Personal Genome Diagnostics’ TMB Analysis Shows Promising Checkpoint Inhibitor Efficacy in Early-Stage Lung Cancer Study